GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (XMAD:ORY) » Definitions » Shiller PE Ratio

Oryzon Genomics (XMAD:ORY) Shiller PE Ratio : (As of Apr. 26, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Oryzon Genomics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Oryzon Genomics Shiller PE Ratio Historical Data

The historical data trend for Oryzon Genomics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics Shiller PE Ratio Chart

Oryzon Genomics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oryzon Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Oryzon Genomics's Shiller PE Ratio

For the Biotechnology subindustry, Oryzon Genomics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oryzon Genomics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oryzon Genomics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Oryzon Genomics's Shiller PE Ratio falls into.


;
;

Oryzon Genomics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Oryzon Genomics's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Oryzon Genomics's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.02/123.1207*123.1207
=-0.020

Current CPI (Sep. 2024) = 123.1207.

Oryzon Genomics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.000 100.251 0.000
201503 -0.026 99.474 -0.032
201506 0.027 101.138 0.033
201509 -0.014 99.559 -0.017
201512 -0.023 100.268 -0.028
201603 -0.026 98.638 -0.032
201606 -0.075 100.333 -0.092
201609 -0.049 99.737 -0.060
201612 -0.047 101.842 -0.057
201703 -0.046 100.896 -0.056
201706 -0.043 101.848 -0.052
201709 -0.035 101.524 -0.042
201712 -0.039 102.975 -0.047
201803 -0.031 102.122 -0.037
201806 0.047 104.165 0.056
201809 -0.029 103.818 -0.034
201812 -0.020 104.193 -0.024
201903 -0.031 103.488 -0.037
201906 -0.014 104.612 -0.016
201909 -0.022 103.905 -0.026
201912 -0.021 105.015 -0.025
202003 -0.026 103.469 -0.031
202006 -0.004 104.254 -0.005
202009 -0.017 103.521 -0.020
202012 -0.021 104.456 -0.025
202103 -0.034 104.857 -0.040
202106 0.015 107.102 0.017
202109 -0.026 107.669 -0.030
202112 -0.040 111.298 -0.044
202203 -0.031 115.153 -0.033
202206 0.006 118.044 0.006
202209 -0.010 117.221 -0.011
202212 -0.041 117.650 -0.043
202303 -0.029 118.948 -0.030
202306 0.018 120.278 0.018
202309 -0.020 121.343 -0.020
202312 -0.027 121.300 -0.027
202403 -0.019 122.762 -0.019
202406 0.002 124.409 0.002
202409 -0.020 123.121 -0.020

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Oryzon Genomics  (XMAD:ORY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Oryzon Genomics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oryzon Genomics Business Description

Traded in Other Exchanges
Address
Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.

Oryzon Genomics Headlines

No Headlines